... Bispecific Antibody for Small Cell Lung CancerAnother bispecific antibody, tarlatamab-dlle (Imdelltra), was approved in 2024 to treat extensive-stage small cell lung cancer. It may be used in people whose cancer has progressed despite treatment with platinum-based chemotherapy.6. ...
New Lung Cancer Treatments: 9 Advancements in Research
... Bispecific Antibody for Small Cell Lung CancerAnother bispecific antibody, tarlatamab-dlle (Imdelltra), was approved in 2024 to treat extensive-stage small cell lung cancer. It may be used in people whose cancer has progressed despite treatment with platinum-based chemotherapy.6. ...
... One example is tarlatamab-dlle (Imdelltra), which works by binding to lung cancer cells and immune cells, bringing them closer together so the immune system can target the cancer more effectively.Palliative CarePalliative care for lung cancer focuses on treatments and medications that help relieve symptoms and improve quality of life during any stage ...
Lung Cancer Treatment Options
... One example is tarlatamab-dlle (Imdelltra), which works by binding to lung cancer cells and immune cells, bringing them closer together so the immune system can target the cancer more effectively.Palliative CarePalliative care for lung cancer focuses on treatments and medications that help relieve symptoms and improve quality of life during any stage ...